Southwest Airlines enters the back half of May carrying two storylines that cut in opposite directions. Elliott Investment Management has sharply reduced its position. Meanwhile, short sellers have been quietly adding exposure through the week, even as the stock shed nearly 7%.
The clearest institutional signal this week came from Elliott. The activist fund trimmed its stake to 30.35 million shares — down from a reported 57.17 million — a reduction of nearly 47% in one filing. Elliott built its position as the catalyst for sweeping strategic change at Southwest, pushing for board turnover, a review of network and seating strategy, and CEO accountability. That pressure yielded results: the airline introduced assigned seating, launched basic economy, and has been restructuring its route network. With those changes now embedded, Elliott's exit reduces the near-term activist premium baked into the stock. The shares closed at $38.50 on Friday, down 2.1% on the day and off 6.8% for the week.
Short interest has been rebuilding quietly but at a measured pace. The SI % of FF climbed from roughly 4.25% at the start of the week to 4.58% by May 14 — a 7.4% rise in short shares over seven days, the fastest weekly accumulation in six weeks. The absolute level remains modest. The borrow market reflects this: cost to borrow is only 0.43% annualised, up about 34% week-on-week but still near the cheapest levels in the 30-day window. Availability is loose, with lending pool utilisation running at just 5.3% — far below the 52-week high of 27.9%. There is no squeeze pressure here. Short sellers are rebuilding positions into a falling stock, not fighting for scarce borrow.
Options traders are running close to their recent average. The put/call ratio of 0.62 is marginally below its 20-day mean of 0.64, with a z-score of just -0.44. That is not a market rushing to buy downside protection — it is broadly neutral. The 52-week range for the PCR spans 0.57 to 1.56, so the current reading is well towards the call-heavy end of the full range, suggesting no acute fear in the options market despite the week's sell-off.
The Street holds a mixed view. The mean analyst price target is around $45.25, implying roughly 18% upside from current levels. The most recent actions in late April told different stories: Jefferies trimmed its target to $37 while keeping Hold, while HSBC upgraded from Reduce to Hold and lifted its target to $36.10. Evercore ISI nudged its target marginally higher to $44. The bull case rests on assigned seating generating new revenue streams and cost discipline from the ongoing restructuring. The bear case focuses on execution risk in that very transition, load factor pressure, and vulnerability on close-in leisure fares. The ORTEX short score of 37.9 — mid-range and only slightly higher than last week — does not signal an extreme positioning in either direction. The analyst consensus divergence factor score sits at an elevated 93rd percentile, pointing to unusually wide disagreement across the coverage universe on where the stock should trade.
The earnings calendar puts the next print on July 23. The last two quarterly results showed a consistent pattern: a near-flat 1-day reaction followed by a 3-5% drift lower over the subsequent week. On April 22, following the Q1 release, the stock fell 7.7% on the day and extended to a 9% five-day loss. The May 7 event — a separate announcement — produced only a -0.5% day-one move with a -5.2% five-day drift. That 5-day drift pattern across multiple prints signals the market has been using any initial stability as an opportunity to reduce exposure. The restructuring layoffs announced this week — around 75 roles in an organisational reshaping — are small in scale but confirm the cost programme is still active. The next focal point is whether Q2 load factor data, due before the July print, shows any improvement in the close-in booking environment that analysts have flagged as a revenue vulnerability.
See the live data behind this article on ORTEX.
Open LUV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
